Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06644989 · ClinicalTrials.gov registry record · NA
Impact of Osteopathic Manipulative Therapy on Hip Range of Motion
A NA study, sponsored by Lake Erie College of Osteopathic Medicine.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT06644989: Completed NA study, sponsored by Lake Erie College of Osteopathic Medicine.
NCT06644989 is a NA study that has completed, run by Lake Erie College of Osteopathic Medicine. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06644989, a NA study, has completed, sponsored by Lake Erie College of Osteopathic Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
One way for runners to improve their performance and remain injury free is to preserve and improve joint mobility, especially at the hips. The femoroacetabular joints are a pivotal part of the running gait allowing the athlete to fully extend their leg to generate sufficient force in each stride. Improving hip range of motion can help reduce or prevent groin pain, make the runner more comfortable while running, improve running longevity, and prevent injuries. Thus, it is clear that a runner's commitment to improving the range of motion of their hips is crucial for both the enhancement of their performance and prevention of injury. Researchers assessed how the hip, and its biomechanics, can be impacted by Osteopathic medical treatment. The primary research question investigated is how Spencer Technique for the hip impacts femoral acetabular active range of motion (AROM) in flexion, extension, abduction, adduction, internal rotation, and external rotation in those training 4 weeks for a 5K race. This study investigated the effect that 4 weeks of twice weekly, bilateral, Spencer Technique treatment had on femoroacetabular range of motion. During this 4-week period participant exercise and stretching habits in preparation for the 5k race were recorded.
Primary Outcome
Hip range of motion (flexibility) is measured to monitor changes in flexibility
Interventions
- OTHER Sham (No Treatment)
- PROCEDURE Spencer Technique
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-01-01 |
| Est. Completion | 2024-02-29 |
| Phase | NA |
What the finished NCT06644989 record still lists
NCT06644989 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Sham (No Treatment) is the first listed.
NCT06644989 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06644989 about?
NCT06644989 is a clinical study titled "Impact of Osteopathic Manipulative Therapy on Hip Range of Motion". One way for runners to improve their performance and remain injury free is to preserve and improve joint mobility, especially at the hips. The femoroacetabular joints are a pivotal part of the running gait allowing the athlete to fully extend their leg to generate sufficient force in each stride. Im...
What is the current status of trial NCT06644989?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2024-01-01. Estimated completion is 2024-02-29.
What interventions are being tested in trial NCT06644989?
The interventions under investigation include: Sham (No Treatment) (OTHER), Spencer Technique (PROCEDURE).
Who is sponsoring clinical trial NCT06644989?
This trial is sponsored by Lake Erie College of Osteopathic Medicine, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06644989's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI